To provide for a disregard under the Supplemental Security Income program of compensation for participation in clinical trials for rare diseases or conditions.
The bill’s titles are written by its sponsor.
Jun 15, 2009
111th Congress, 2009–2010
Died in a previous Congress
This bill was introduced on June 15, 2009, in a previous session of Congress, but was not enacted.
Representative for Massachusetts's 7th congressional district
Read Text »
Last Updated: Jun 15, 2009
Length: 5 pages
- See Instead:
S. 1674 (same title)
Enacted — Signed by the President — Oct 5, 2010
This is the first step in the legislative process.
H.R. 2866 (111th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
This bill was introduced in the 111th Congress, which met from Jan 6, 2009 to Dec 22, 2010. Legislation not enacted by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
Civic Impulse. (2016). H.R. 2866 — 111th Congress: Improving Access to Clinical Trials Act of 2009. Retrieved from https://www.govtrack.us/congress/bills/111/hr2866
“H.R. 2866 — 111th Congress: Improving Access to Clinical Trials Act of 2009.” www.GovTrack.us. 2009. October 24, 2016 <https://www.govtrack.us/congress/bills/111/hr2866>
|title=H.R. 2866 (111th)
|accessdate=October 24, 2016
|author=111th Congress (2009)
|date=June 15, 2009
|quote=Improving Access to Clinical Trials Act of 2009
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.